Portfolio News

NeurAxon Named One of Canada’s Top 10™ Life Science Companies

August 21, 2012

TORONTO, ON. October 14, 2010 — NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), has been named as one of Canada’s Top 10™ Life Science Companies and was also given the award for the Best Company Presentation in the Life Sciences Technologies Stream of the Banff Venture Forum.

Cytochroma Initiates Phase 3 Study

September 2, 2012

Markham, Ontario, Canada — September 20, 2012 — Cytochroma today announced the initiation of a phase 3 study of CTAP101 capsules ("CTAP101 Capsules") in patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Aimetis Expands Distribution in Asia

June 21, 2012

Aimetis Expands Distribution in Asia

Waterloo, ON - Aimetis Corp., a global leader in intelligent video management software, has signed distribution agreements with Mixpole, Xiatong Network, The Certis Group and Shanghai Vitlon Intelligent Technology Co to add Aimetis Symphony™ software to their physical security product line.

CounterPath Announces Closing of Private Placement

June 19, 2012

Vancouver, BC, Canada — June 19, 2012CounterPath Corporation (“CounterPath” or the “Company”) (TSX-V: CCV) (OTCBB: CPAH), an award-winning provider of desktop and mobile VoIP software products and solutions, today announced that it has raised gross proceeds of CDN$3,662,500 (US$3,597,000) by way of a previously announced non-brokered private placement (the “Offering”) of units at a price of CDN$2.50 per unit (the “Units”).

Cloud Automates, Eases Subscription-Billing Process Pains

July 5, 2012

Alison Diana, Editor in Chief, 7/5/2012

If they are tired of dealing with billing issues internally, SMBs and solution providers have the option of sending billing to the cloud, a process that removes manual errors and slowdowns, and gives businesses the flexibility to more easily experiment with pricing and special offers.

Embotics Names Stephen Pollack to Board of Directors

August 9, 2012

Ottawa, August 9, 2012Embotics Corporation, a pioneer in virtualization and cloud management, today announced that virtualization industry veteran Stephen Pollack has joined the Embotics Board of Directors. Pollack will provide his unique perspective to help shape Embotics’ strategic plan for product and company growth.

Embotics Secures $8.4M in Financing

May 12, 2012

June 12, 2012 - OTTAWA, Ontario - (Business Wire) - Embotics Corporation, a leader in virtualization and

EGI Financial Holdings Profits up 25% in Q1 2012

May 10, 2012

TORONTO, May 10, 2012 ‐ EGI Financial Holdings Inc. (“EGI” or “the Company”) (TSX: EFH), which operates in the property and casualty insurance industry in Canada, the United States and Europe, today reported a net income of $3.8 million, or $0.33 per basic and diluted share, for the first quarter ended March 31, 2012, a 25% increase over the first quarter of 2011.

First Quarter Highlights

CounterPath Lists on NASDAQ

July 11, 2012

New York - July 11, 2012 - CounterPath Corporation (the “Company”) commenced trading on the NASDAQ Capital Market under the symbol “CPAH”. The stock is also traded on the TSX under the symbol “CCV”.

The Company’s listing on NASDAQ, which closely followed the completion of a successful (CDN)$3.66 million private placement in June of this year, underscores CounterPath’s steady growth since its inception in 2002.

Covington Group of Funds Successfully Exits PlateSpin Ltd. Investment

March 31, 2008

Covington Group of Funds (“Covington”) is pleased to announce that Novell, Inc. (“Novell”) has completed its acquisition of Covington investee PlateSpin Ltd. (the “Company”). The acquisition for USD$205 million (all cash transaction) will see PlateSpin’s customers benefit from the larger resources and global reach provided by the amalgamation of the two entities.